PATENT CLAIM ANALYSIS

Application Number: 15750086
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["424", "001890"]

Abstract:
This disclosure relates to methylsulfonamide derivatives and uses as imaging agents and other uses related to CXCR4 inhibition. In certain embodiments, the disclosure relates to pharmaceutical compositions comprising compounds disclosed herein, derivatives, or pharmaceutically acceptable salts or prodrugs thereof. In certain embodiments, the compositions disclosed herein are used for imaging to study CXCR4 related conditions.

Claim (Index 13):
The method of  claim 12 , wherein the other active agent is a non-steroidal anti-inflammatory drugs (NSAIDs), ibuprofen, acetaminophen, methotrexate, abatacept, adalimumab, azathioprine, ciclosporin, rituximab, chloroquine, hydroxychloroquine, etanercept, golimumab, infliximab, leflunomide, minocycline, or combinations thereof

Metadata:
- Claim Count in Document: 1.0
- Percentile: 88.0
- Lexical Diversity: 1.63158
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15558971', '15311573', '15728459', '14911807', '14234127']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.845637059058465
- 35 USC 102 Novelty (BERT): 0.5673223968903414
- Combined Prediction Score: 0.8178055928416527
- Mean Citation Score: 512.9042320000002
- Max Citation Score: 519.001
- Similarity Product: 331.759221699357

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test